EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Quantitative prediction of intravenous drug interactions caused by cytochromes P450 inhibitors and inducers

Vianney Tuloup iD, Michel Tod iD, Laurent Bourguignon iD

British Journal of Clinical Pharmacology · 2026-08 · 92 (8) · 2682-2692

DOI: 10.1002/bcp.70548 ↗

At a glance

Journal article in British Journal of Clinical Pharmacology, published online on 2026-04-04. Written by Vianney Tuloup and 2 co-authors. Institution: Pharmacy Department, CHRU Tours, Tours, France. Major MEDLINE topics: Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Enzyme Inducers, Models, Biological. 94 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Aims Pharmacokinetic interaction studies typically focus on oral administration, but intravenous (IV) administration bypasses intestinal degradation and hepatic first‐pass metabolism, leading to distinct drug–drug interaction (DDI) magnitude. This study aimed to develop a predictive model for DDIs involving IV‐administered drugs.

Methods

Drugs metabolized by the five major cytochrome P450 enzymes were analysed. Data from IV DDI studies, including area under the concentration‐time curve (AUC) ratios of object drugs with and without precipitants, were collected. A Bayesian approach estimated IV contribution ratios (CR) from published oral CR values. Predictions were validated by assessing whether predicted‐to‐observed ratios fell within 50–200% of observed values.

Results

Data for 33 drugs and 87 AUC ratios involving 26 precipitants were analysed. In the training set, 95% of AUC ratios were within the acceptability range, with a mean bias of 0.09 mg·h/L and 16% imprecision. In the validation set, 85% of predictions were within range, with a bias of −0.012 mg·h/L and 27.3% imprecision. Mean AUC ratios for inhibitors were 2.28 (oral) and 1.78 (IV). For inducers, mean AUC ratios were 0.209 (oral) and 0.62 (IV).

Conclusions

Despite the limited dataset, the model demonstrated robust performance with 85% of predictions validated. It expands the DDI‐predictor framework for quantitative prediction of cytochrome‐mediated drug–drug interactions affecting drug exposure to intravenously administered object drugs, thereby providing a tool to predict and understand IV‐specific DDIs effectively.

Subjects

MeSH terms (MEDLINE)

Cytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme InducersModels, BiologicalDrug InteractionsHumansArea Under CurveBayes TheoremAdministration, IntravenousCytochrome P-450 Enzyme System

Author keywords

cytochrome P450drug interactionsmodelling and simulationpharmacometrics

Substances

Cytochrome P-450 Enzyme InhibitorsCytochrome P-450 Enzyme InducersCytochrome P-450 Enzyme System

Authors and institutions

  • Pharmacy Department, CHRU Tours, Tours, France.
  • Pharmacy Faculty, Tours University, Tours, France.
  • Inserm 1327 ISCHEMIA, Tours University, Tours, France.
  • Pharmacology-Physiology-Toxicology Department, ISPB Pharmacy Faculty of Lyon, University of Lyon, Lyon, France.
  • Laboratoire de Biométrie et Biologie Évolutive, Univ Lyon, Université Claude Bernard Lyon 1, UMR CNRS 5558, Villeurbanne, France.
  • Pharmacy Department, University Hospital of Lyon, GH Nord, Lyon, France.

ORCID profiles: Vianney Tuloup, Michel Tod, Laurent Bourguignon

Cite

APA

Tuloup, V., Tod, M., & Bourguignon, L. (2026). Quantitative prediction of intravenous drug interactions caused by cytochromes P450 inhibitors and inducers. British Journal of Clinical Pharmacology, 92(8), 2682-2692. https://doi.org/10.1002/bcp.70548

Vancouver

Tuloup V, Tod M, Bourguignon L. Quantitative prediction of intravenous drug interactions caused by cytochromes P450 inhibitors and inducers. British Journal of Clinical Pharmacology. 2026;92(8):2682-2692. doi:10.1002/bcp.70548

BibTeX
@article{Tuloup2026,
  author = {Tuloup, Vianney and Tod, Michel and Bourguignon, Laurent},
  title = {Quantitative prediction of intravenous drug interactions caused by cytochromes P450 inhibitors and inducers},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  volume = {92},
  number = {8},
  pages = {2682--2692},
  doi = {10.1002/bcp.70548}
}
Start for free →